chronic graft versus host disease after allogeneic bone marrow transplantation; an analysis of incidence and risk factors.

نویسندگان

a ghavamzadeh hematology- oncology and bmt research center, shariati hospital, tehran, iran

k alimoghaddam hematology- oncology and bmt research center, shariati hospital, tehran, iran

b bahar hematology- oncology and bmt research center, shariati hospital, tehran, iran

f foroughi hematology- oncology and bmt research center, shariati hospital, tehran, iran

چکیده

background: chronic graft versus host disease (cgvhd) is one of the most serious potential complications of allogeneic bone marrow transplantation. study design and method: we analyzed the incidence of cgvhd and its associated risk factors in a group of 161 iranian recipients of hla-identical sibling transplants, with at least 90 days post-transplantation survival. in the majority of cases (n=73), cgvhd occurred in the first year after the transplant (median 273 days). the actual probability of cgvhd within 1 year was 45.3±7% (ci 95%). results: in a univariate analysis, the most important risk factor was the type of transplant. peripheral blood stem cell transplants (pbsct) showed a significant increase in cgvhd compared with bone marrow transplants (bmt) (rr=2.34, p<0.001). in addition, male recipients were at a greater risk than female recipients (rr=2.08, p=0.004). other risk factors were the presence of prior acute gvhd (rr=2.37, p=0.04) and the previous acute gvhd grade (p=0.03); the probabilities of cgv d in patients with grade 0, ι, ιі, ιιι, ιv acute gvhd were 24%, 44.7%, 42.6%, 56.8%, 64.3%, respectively. conclusion: in a multivariate analysis, the only independent predictive factors for the development of cgvhd were the type of transplant (pbsc>bm, p<0.001) and male recipient (p=0.005). the survival rate was 88.8% and there was no significant difference in the probability of survival between bpsct vs bmt (93.8% vs 86.6%, p=0.5).

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation.

Chronic graft-versus-host disease (GVHD) is an important complication of bone marrow transplantation. We analyzed risk factors for chronic GVHD in 2,534 recipients of HLA-identical sibling transplants surviving at least 90 days after transplantation. The actuarial probability of developing chronic GVHD within three years posttransplant was 46% +/- 3% (95% confidence interval). The most importan...

متن کامل

Graft versus host disease following allogeneic bone marrow transplantation.

Graft versus host disease is a major barrier in allogeneic bone marrow transplantation. The associated morbidity and mortality need to be understood and prevented if possible, as the potential indications for bone marrow transplantation continue to broaden. Areas of investigation include the cellular effector arm as well as the cytokines associated with the expression of the disease.

متن کامل

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis.

PURPOSE Controversy exists as to whether the incidence of graft-versus-host disease (GVHD) is increased after peripheral-blood stem-cell transplantation (PBSCT) when compared with bone marrow transplantation (BMT). We performed a meta-analysis of all trials comparing the incidence of acute and chronic GVHD after PBSCT and BMT reported as of June, 2000. Secondary analyses examined relapse rates ...

متن کامل

Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.

Previous studies of risk factors for acute graft-versus-host disease (GVHD) involved patients receiving predominantly single-agent prophylaxis. Therefore, a retrospective analysis was performed on 446 patients, from a single institution, who received transplants of marrow from HLA-identical siblings and the combination of cyclosporine (CSP) and methotrexate (MTX) to determine risk factors for a...

متن کامل

Combined nifuroxazide and SAT05f therapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation

Acute graft-versus-host disease (aGvHD) is the major barrier to the broader use of allogenetic hematopoietic stem cells. However, currently these are no highly specific and efficient drugs. Monotherapy is not sufficient and more efficient and safe therapeutic regimen are urgent need. Studies demonstrated TLR9 and Stat3 signal pathways are critical for antigen-presenting cell maturation and T-ce...

متن کامل

Immunoelectron microscopy of acute graft versus host disease of the skin after allogeneic bone marrow transplantation.

AIMS To clarify the pathological mechanisms of acute cutaneous graft versus host disease (GvHD) following allogeneic bone marrow transplantation. METHODS Skin biopsy specimens from five patients were examined by immunoelectron microscopy. A panel of monoclonal antibodies against T cell and natural killer cell subpopulations was used, including anti-CD4, -CD8, -CD16b, -CD56, -CD57, and -TCR de...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
international journal of hematology-oncology and stem cell research

جلد ۱، شماره ۱، صفحات ۱۶-۱۹

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023